Parkinsonian syndrome after long-term treatment with clebopride
Identifieur interne : 003791 ( PascalFrancis/Checkpoint ); précédent : 003790; suivant : 003792Parkinsonian syndrome after long-term treatment with clebopride
Auteurs : P. Montagna [Italie] ; A. S. Gabellini ; L. Monari ; E. LugaresiSource :
- Movement disorders [ 0885-3185 ] ; 1992.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:92-0289118Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Parkinsonian syndrome after long-term treatment with clebopride</title><author><name sortKey="Montagna, P" sort="Montagna, P" uniqKey="Montagna P" first="P." last="Montagna">P. Montagna</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Inst. neurology</s1><s2>40123 Bologna</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Inst. neurology</wicri:noRegion></affiliation></author><author><name sortKey="Gabellini, A S" sort="Gabellini, A S" uniqKey="Gabellini A" first="A. S." last="Gabellini">A. S. Gabellini</name></author><author><name sortKey="Monari, L" sort="Monari, L" uniqKey="Monari L" first="L." last="Monari">L. Monari</name></author><author><name sortKey="Lugaresi, E" sort="Lugaresi, E" uniqKey="Lugaresi E" first="E." last="Lugaresi">E. Lugaresi</name></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">92-0289118</idno><date when="1992">1992</date><idno type="stanalyst">PASCAL 92-0289118 INIST</idno><idno type="RBID">Pascal:92-0289118</idno><idno type="wicri:Area/PascalFrancis/Corpus">003859</idno><idno type="wicri:Area/PascalFrancis/Curation">002F65</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003791</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Parkinsonian syndrome after long-term treatment with clebopride</title><author><name sortKey="Montagna, P" sort="Montagna, P" uniqKey="Montagna P" first="P." last="Montagna">P. Montagna</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Inst. neurology</s1><s2>40123 Bologna</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Inst. neurology</wicri:noRegion></affiliation></author><author><name sortKey="Gabellini, A S" sort="Gabellini, A S" uniqKey="Gabellini A" first="A. S." last="Gabellini">A. S. Gabellini</name></author><author><name sortKey="Monari, L" sort="Monari, L" uniqKey="Monari L" first="L." last="Monari">L. Monari</name></author><author><name sortKey="Lugaresi, E" sort="Lugaresi, E" uniqKey="Lugaresi E" first="E." last="Lugaresi">E. Lugaresi</name></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="1992">1992</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiemetic</term><term>Case study</term><term>D2 Dopamine receptor</term><term>Dopamine antagonist</term><term>Human</term><term>Long term</term><term>Toxicity</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Toxicité</term><term>Homme</term><term>Etude cas</term><term>Long terme</term><term>Clébopride</term><term>Antiémétique</term><term>Récepteur dopaminergique D2</term><term>Antagoniste dopamine</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>7</s2></fA05><fA06><s2>1</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Parkinsonian syndrome after long-term treatment with clebopride</s1></fA08><fA11 i1="01" i2="1"><s1>MONTAGNA (P.)</s1></fA11><fA11 i1="02" i2="1"><s1>GABELLINI (A. S.)</s1></fA11><fA11 i1="03" i2="1"><s1>MONARI (L.)</s1></fA11><fA11 i1="04" i2="1"><s1>LUGARESI (E.)</s1></fA11><fA14 i1="01"><s1>Inst. neurology</s1><s2>40123 Bologna</s2><s3>ITA</s3></fA14><fA20><s1>89-90</s1></fA20><fA21><s1>1992</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000023029590180</s5></fA43><fA44><s0>0000</s0></fA44><fA45><s0>9 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>92-0289118</s0></fA47><fA60><s1>P</s1><s3>CC</s3></fA60><fA61><s0>A</s0></fA61><fA64 i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC02 i1="01" i2="X"><s0>002B02U01</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Toxicité</s0></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Toxicity</s0></fC03><fC03 i1="01" i2="X" l="GER"><s0>Giftigkeit</s0></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Toxicidad</s0></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Human</s0></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Etude cas</s0></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Case study</s0></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Estudio caso</s0></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Long terme</s0></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Long term</s0></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Largo plazo</s0></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Clébopride</s0><s2>NK</s2><s2>FR</s2></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Antiémétique</s0></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Antiemetic</s0></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Antiemético</s0></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0></fC03><fC03 i1="07" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0><s6>«D2» Dopamine receptor</s6></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Antagoniste dopamine</s0></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Dopamine antagonist</s0></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Antagonista dopamina</s0></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0></fC07><fN21><s1>198</s1></fN21></pA></standard></inist><affiliations><list><country><li>Italie</li></country></list><tree><noCountry><name sortKey="Gabellini, A S" sort="Gabellini, A S" uniqKey="Gabellini A" first="A. S." last="Gabellini">A. S. Gabellini</name><name sortKey="Lugaresi, E" sort="Lugaresi, E" uniqKey="Lugaresi E" first="E." last="Lugaresi">E. Lugaresi</name><name sortKey="Monari, L" sort="Monari, L" uniqKey="Monari L" first="L." last="Monari">L. Monari</name></noCountry><country name="Italie"><noRegion><name sortKey="Montagna, P" sort="Montagna, P" uniqKey="Montagna P" first="P." last="Montagna">P. Montagna</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003791 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 003791 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:92-0289118
|texte= Parkinsonian syndrome after long-term treatment with clebopride
}}
| This area was generated with Dilib version V0.6.23. |  |